Measuring herpes zoster, zoster‐associated pain, post‐herpetic neuralgia‐associated loss of quality of life, and healthcare utilization and costs in Thailand

Aunhachoke, Kobkul; Bussaratid, Valai; Chirachanakul, Pornchai; Chua-Intra, Boosbun; Dhitavat, Jittima; Jaisathaporn, K; Kaewkungwal, Jaranit; Kampirapap, Kowit; Khuhaprema, Thiravud; Pairayayutakul, Kulprapat; Pitisuttithum, Punnee; Sindhvananda, Jirot; Thaipisuttikul, Yupin

doi:10.1111/j.1365-4632.2010.04715.x

Cited by 36 publications

(48 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The increasing likelihood of problems with age is illustrated by the study of Aunhachoke et al [12], in which 76.7% of patients aged ≥50 years were at higher risk for postherpetic neuralgia than younger patients.…”

Section: Discussionmentioning

confidence: 99%

“…There were 7 articles identified that reported the use of EQ-5D in cost-of-illness studies [9,10,11,12,13,14,15] (table 2). These studies confirm that different skin conditions are associated with different burdens of disease, which can be measured by a variety of methods to evaluate costs and benefits.…”

Section: Resultsmentioning

confidence: 99%

“…The literature search identified 19 articles and 1 abstract (published between 2003 and 2011), in which were described 7 cost-of-illness analyses [9,10,11,12,13,14,15], 1 cost-effectiveness analysis [16] and 13 cost-utility analyses [16,17,18,19,20,21,22,23,24,25,26,27,28]. …”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

et al. 2012

View full text Add to dashboard Cite

Economic evaluation is an increasingly important aspect of assessment of the burden of skin diseases. Although dermatology data were not used in its development, the use of the EQ-5D questionnaire has been encouraged by the requirement of health technology assessment agencies for utility comparisons informing reimbursement decisions. The aim of this review was to examine the use of the EQ-5D in dermatology and to consider its future role in the economic evaluation of skin diseases. Published studies reporting the use of the EQ-5D in the economic analysis of skin diseases were carefully examined. Nineteen articles and 1 abstract published between 2003 and 2011 were identified, in which cost-of-illness, cost-effectiveness and cost-utility analyses were described. The EQ-5D is not a dermatology-specific measure, and it is not yet clear whether it is the most appropriate measure to support economic evaluation in the context of dermatology.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

et al. 2012

View full text Add to dashboard Cite

show abstract

“…The authors found that 9 of 77 working patients had taken 6.8 ± 6.9 d of sick leave, 9.0 ± 6.9 d of disability leave, and 11.3 ± 5.7 d off work. 41 Another 34 patients needed a hospital chaperone or a caregiver. Caregivers were more often needed by patients suffering from cancer.…”

Section: Hospitalization Costsmentioning

confidence: 99%

Evaluation of the economic burden of Herpes Zoster (HZ) infection

Panatto

Bragazzi

Rizzitelli

et al. 2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

The main objective of this systematic review was to evaluate the economic burden of Herpes Zoster (HZ) infection. The review was conducted in accordance with the standards of the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" guidelines. The following databases were accessed: ISI/Web of Knowledge (WoS), MEDLINE/PubMed, Scopus, ProQuest, the Cochrane Library and EconLit. Specific literature on health economics was also manually inspected. Thirty-three studies were included. The quality of the studies assessed in accordance with the Consolidated Health Economic Evaluation Reporting Standards checklist was good. All studies evaluated direct costs, apart from one which dealt only with indirect costs. Indirect costs were evaluated by 12 studies. The economic burden of HZ has increased over time. HZ management and drug prescriptions generate the highest direct costs. While increasing age, co-morbidities and drug treatment were found to predict higher direct costs, being employed was correlated with higher indirect costs, and thus with the onset age of the disease. Despite some differences among the selected studies, particularly with regard to indirect costs, all concur that HZ is a widespread disease which has a heavy social and economic burden.

show abstract

“…Several studies assessed the economic burden of HZ and PHN, showing that they are frequent and costly conditions, also in terms of impact on quality of life, as discussed above (Scott et al, 2006;Stein et al,2009;Gil et al, 2009;Gialloreti et al, 2010;Aunhachoke et al, 2011;Hornberger & Robertus, 2006). For instance, in Italy a recent study estimated that total annual costs for HZ and PHN were €41.2 Million, including both direct and indirect costs (Gialloreti et al, 2010).…”

Section: Can Phn Be Prevented?mentioning

confidence: 99%

Zoster-Associated Pain and Post Herpetic Neuralgia

Ursini¹,

Tontodonati²,

Polilli³

et al. 2012

Herpesviridae - A Look Into This Unique Family of Viruses

View full text Add to dashboard Cite

Measuring herpes zoster, zoster‐associated pain, post‐herpetic neuralgia‐associated loss of quality of life, and healthcare utilization and costs in Thailand

Abstract: Herpes zoster contributes a significant burden of illness to both patients and the wider community.

Cited by 36 publications

References 19 publications

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies

Evaluation of the economic burden of Herpes Zoster (HZ) infection

Zoster-Associated Pain and Post Herpetic Neuralgia

Contact Info

Product

Resources

About